Carboplatin, in combination with epirubicin and 5-fluorouracil or capecitabine for advanced oesphagogastric cancer patients not suitable for standard cisplatin based combination treatment

Razak A. Abdul, S. Lyon, C. Yates, R. Todd, P. Atherton,P. Mulvenna,K. Sumpter,F. Coxon

ANNALS OF ONCOLOGY(2008)

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined